indirubin-3'-monoxime has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajagopalan, P | 1 |
| Dera, A | 1 |
| Abdalsamad, MR | 1 |
| C Chandramoorthy, H | 1 |
| Ahn, MY | 1 |
| Kim, TH | 1 |
| Kwon, SM | 1 |
| Yoon, HE | 1 |
| Kim, HS | 1 |
| Kim, JI | 1 |
| Kim, YC | 1 |
| Kang, KW | 1 |
| Ahn, SG | 1 |
| Yoon, JH | 1 |
2 other studies available for indirubin-3'-monoxime and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associ | 2019 |
5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tu | 2015 |